Bigatra 110 Mg Tablet

What is Bigatra 110

Bigatra 110 is an oral anticoagulant containing Dabigatran Etexilate, belonging to the direct thrombin inhibitor class. It is a blood thinner primarily used in blood clot prevention in various medical conditions. Doctors prescribe it to reduce stroke risk in non-valvular atrial fibrillation, and also to treat Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE) and prevent their recurrence.

Bigatra works by directly inhibiting thrombin, an enzyme that helps in blood clot formation. By blocking thrombin, the medicine helps to prevent harmful clots from forming in the bloodstream, reducing the chances of stroke, heart attack, and embolism-related complications.

Unlike traditional anticoagulants like Warfarin, Bigatra offers a more predictable effect and does not require frequent blood monitoring. Additionally, it starts working faster than Warfarin and has fewer food interactions.

Avoid sudden discontinuation of the medicine, as it may lead to severe clot formation. It may cause bleeding disorders hence, avoid NSAIDs and Aspirin. It is not suitable for patients with active bleeding, recent surgery, or severe ulcers. If surgery or dental procedures are planned, inform your doctor beforehand.

It is manufactured and marketed by Aprica Pharmaceuticals Private Limited in GMP-compliant facilities.

What are the benefits of taking Bigatra 110

Bigatra contains Dabigatran Etexilate, a direct thrombin inhibitor that works by blocking thrombin, an enzyme essential for blood clot formation. Normally, thrombin converts fibrinogen into fibrin, creating a stable clot. By inhibiting thrombin, Bigatra prevents fibrin formation, thereby reducing the risk of clot-related conditions like stroke, DVT, and PE.

Unlike Warfarin, which requires constant INR monitoring and has several dietary restrictions, Bigatra 110 provides predictable anticoagulation without regular blood tests. It starts working within hours after administration, making it a faster alternative to traditional blood thinners.

Additionally, the drug’s fixed dosing makes it easier to use, eliminating the need for frequent adjustments.

Bigatra is widely preferred because of its ease of use, safety profile, and effectiveness in clot prevention. However, proper adherence is crucial to avoid complications like excessive bleeding or clot formation.

How to take Bigatra 110

Taking Bigatra correctly is essential to ensure its effectiveness and minimize the risk of complications. Follow your doctor’s instructions carefully and maintain a consistent routine for the best results.

• Take at the same time each day, as prescribed by your doctor.
• Swallow the tablet with water. Do not crush or chew it.
• It can be taken with or without food, but taking it with food can reduce stomach discomfort.
• Typically, once or twice daily, based on your condition.

Strengths and substitutes

You can find Bigatra in various strengths on Cheap Medicine Shop:

View All Substitutes

What are the side effects of Bigatra 110

While Bigatra 110 is generally well tolerated, some patients may experience some side effects. The side effects of Bigatra tablet include:

• Nosebleeds
• Gum bleeding
• Indigestion
• Nausea
• Bloating
• Stomach pain
• Bruising easily

Seek immediate medical attention if the above-mentioned effects do not subside or cause discomfort.

Safety Advice

Liver disease

Patients with liver disease should take it with caution. Since the medication affects blood clotting, it may increase bleeding risks in individuals with compromised liver function.

Kidney impairment

Doctors may prescribe a lower dose or alternative anticoagulants for individuals with kidney issues.

Pregnant and breastfeeding women

Bigatra is not recommended during pregnancy unless prescribed by a doctor. It can increase bleeding risk in both mother and baby. Since Dabigatran may pass into breast milk, it is generally not recommended for nursing mothers. Doctors may suggest alternative blood thinners.

Avoid

Avoid consuming alcohol, as it worsens stomach irritation and bleeding tendencies.